Cargando…
Regulation of Autophagy Progress via Lysosomal Depletion by Fluvastatin Nanoparticle Treatment in Breast Cancer Cells
[Image: see text] Fluvastatin (FLV) is a statin family member that may play a role in modulating a variety of medical disorders such as atherosclerosis and breast cancer. The present study addresses the ability of FLV to modulate the cellular immune response and provides a new nanosized FLV formula...
Autores principales: | Elimam, Hanan, El-Say, Khalid M., Cybulsky, Andrey V., Khalil, Hany |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331036/ https://www.ncbi.nlm.nih.gov/pubmed/32637822 http://dx.doi.org/10.1021/acsomega.0c01618 |
Ejemplares similares
-
Fluvastatin Prevents Lung Adenocarcinoma Bone Metastasis by Triggering Autophagy
por: Yang, Zuozhang, et al.
Publicado: (2017) -
Genetic Ablation of Calcium-independent Phospholipase A(2)γ Exacerbates Glomerular Injury in Adriamycin Nephrosis in Mice
por: Elimam, Hanan, et al.
Publicado: (2019) -
Enantiospecific Pharmacogenomics of Fluvastatin
por: Hirvensalo, Päivi, et al.
Publicado: (2019) -
Efficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer
por: Bhardwaj, Anjana, et al.
Publicado: (2021) -
Gene signature associated with resistance to fluvastatin chemoprevention for breast cancer
por: Bhardwaj, Anjana, et al.
Publicado: (2022)